Advertisement

Topics

Kineta, Genentech Enter Collaboration

05:01 EDT 16 Apr 2018 | Contract Pharma

To develop Kineta's α9/α10 nicotinic acetylcholine receptor (nAChR) antagonists for the treatment of chronic pain

Original Article: Kineta, Genentech Enter Collaboration

NEXT ARTICLE

More From BioPortfolio on "Kineta, Genentech Enter Collaboration"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pain
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...